¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Scandinavian studies in law."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Avogadro law
    ¾Æº¸°¡µå·Î¹ýÄ¢
  • awaking drug control law
    °¢¼ºÁ¦Á¶Àý¹ý
  • biogenetic law
    »ý¹°¹ß»ý¹ýÄ¢
  • dilution law
    Èñ¼®¹ýÄ¢
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢
  • Hardy-Weinberg law
    ÇϾƵð-¿ÍÀιö±×¹ýÄ¢
  • inverse square law
    ¿ªÀڽ¹ýÄ¢
  • law
    ¹ý, ¹ýÄ¢
  • law of avalanche
    ´«»çŹýÄ¢
  • law of causality
    ÀΰúÀ²
  • law of prophylaxis for infectious disease
    Àü¿°º´¿¹¹æ¹ý
  • law of reflection
    ¹Ý»ç¹ýÄ¢
  • law of regression
    ÅðÇà¹ýÄ¢
  • law of relativity
    »ó´ë¹ýÄ¢
  • law of similars
    À¯Áõ¹ýÄ¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • awaking drug control law
    °¢¼ºÁ¦Á¶Àý¹ý
  • biogenetic law
    »ý¹°¹ß»ý¹ýÄ¢
  • dilution law
    ¹±Èû¹ýÄ¢, Èñ¼®¹ýÄ¢
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢
  • inverse square law
    ¿ªÀڽ¹ýÄ¢
  • law
    ¹ý, ¹ýÄ¢
  • law of avalanche
    ´«»çŹýÄ¢
  • law of causality
    ÀΰúÀ²
  • law of prophylaxis for infectious disease
    Àü¿°º´¿¹¹æ¹ý
  • law of reflection
    ¹Ý»ç¹ýÄ¢
  • law of regression
    ÅðÇà¹ýÄ¢
  • law of relativity
    »ó´ë¼º¹ýÄ¢
  • law of similars
    À¯Áõ¹ýÄ¢
  • law of weights and measures
    °è·®¹ý
  • medical service law
    ÀÇ·á¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • Alexanders law
    ¾Ë·º»ê´õ¹ýÄ¢
  • Beers law
    ºñ¾îÀÇ ¹ýÄ¢
  • Bell-Magendie law
    º§ ¸¶°Õµð ¹ýÄ¢
  • Camerers law
    Ä«¸Þ·¯¹ýÄ¢.
  • Dale-Feldbergs law
    ´ëÀÏ-ÈÔÆ®º£¸£±× ¹ýÄ¢(~ÛööÎ)
  • Einthovens law
    ¿¡ÀÎÅäºì ¹ýÄ¢(ÛööÎ)
  • Ficks first law
    ÇÈÁ¦ÀϹýÄ¢(ÛööÎ).
  • Ficks law of diffusion
    ÇÈÀÇ È®»ê(üªß¤)¹ýÄ¢(ÛööÎ)
  • Frank-Starling law
    ÇÁ·©Å©-½ºÅ»¸µ ¹ýÄ¢(ÛööÎ)
  • Henrys law
    Ç¹ýÄ¢
  • Herings law
    Ç층¹ýÄ¢
  • Hookes law
    ÈÅÀÇ ¹ýÄ¢.
  • Listings law
    ¸®½ºÆÃ¹ýÄ¢
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • real-time studies
    ½Ç½Ã°£ °Ë»ç (ãùãÁÊà ËþÞÛ)
  • all-or-none law =all-or-none principle
    ´Ù³Ä ¾Æ´Ï³ÄÀÇ ¹ýÄ¢, ½Ç¹«À²
  • associative law
    °áÇÕ¹ýÄ¢.
  • awaking drug control law
    °¢¼ºÁ¦Á¶Àý¹ý.
  • biogenetic law
    »ý¹°¹ß»ý¹ýÄ¢(¡­ Û¡ßæÛööÎ).
  • commutative law
    ±³È¯¹ýÄ¢(Ë´Ì·ËÑ̬).
  • dilution law
    ¹±Èû¹ýÄ¢(¡­ÛööÎ), Èñ¼®¹ýÄ¢.
  • distribution law
    ºÐÆ÷¹ýÄ¢(ÊÙËÑ̬).
  • gas law
    ±âü¹ýÄ¢(Ѩô÷ÛööÎ).
  • group displacement law
    Áý´Üº¯À§¹ýÄ¢(ÊÙËÒ ËôËÑ̬).
  • inverse square law
    ¿ªÀڽ¹ýÄ¢
  • law for control of poisonous and powerful agents
    µ¶±Ø¹°Ãëü¹ý(ËÄË»ËŅ̬̃ ËÑ).
  • law of avalanche
    ´«»çÅÂ(¡­ÞÞ÷À)ÀÇ ¹ýÄ¢.
  • law of average
    Æò±Õ¹ýÄ¢(̰˻ËÑ̬).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Beer-Lambert law
    ºñ¾î-¶÷º£¸£ ¹ýÄ¢(ÛööÎ)
  • Beer's law
    ºñ¾î ¹ýÄ¢(ÛööÎ)
  • biogenetic law
    »ý¹°¹ß»ý¹ýÄ¢(ßæÚªÛ¡ßæÛööÎ)
  • Bouguer's law
    ºÎ°Ô ¹ýÄ¢(ÛööÎ)
  • Bronsted catalysis law
    ºê·Ð½ºÅ×µå Ã˸ŹýÄ¢(õºØÚÛööÎ)
  • Clausius'law
    "Ŭ·Î½Ã¿ì½º ¹ýÄ¢(ÛööÎ), (ÔÒ) aphorism of Clausius"
  • distribution law
    "ºÐÆ÷ ¹ýÄ¢(ÝÂøÖÛööÎ), (ÔÒ) partition law"
  • Draper's law
    µå·¡ÆÛ ¹ýÄ¢(ÛööÎ) (ÔÒ) first law of photochemistry
  • Fick's first law
    ÇÈ Á¦ 1 ¹ýÄ¢(ÛööÎ)
  • Fick's second law
    ÇÈ Á¦ 2 ¹ýÄ¢(ÛööÎ)
  • first law of thermodynamics
    ¿­¿ªÇÐ(æðÕôùÊ) Á¦ 1 ¹ýÄ¢(ÛööÎ)
  • Henry's law
    Ç ¹ýÄ¢(ÛööÎ)
  • isodynamic law
    ¾ÆÀ̼ҵ¿Àû(ÔÑîÜ) ¹ýÄ¢(ÛööÎ)
  • kinetic law
    ¿ªÇйýÄ¢(ÕôùÊÛööÎ)
  • Lambert's law
    ¶÷º£¸£¹ýÄ¢(ÛööÎ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • all-or-none law
    ´Ù³Ä¾Æ´Ï³ÄÀÇ ¹ýÄ¢, ½Ç¹«À² ÀüºÎ-Àü¹«¿øÄ¢
  • law
    ¹ýÄ¢
  • medical law
    ÀÇ·á¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CONSENSUS Cooperative North Scandinavian Enalapril Survival Study
SGSG Scandinavian Glioma Study Group
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AAPL American Academy of Psychiatry and the Law
ASLM American Society of Law and Medicine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
CESD Centers for Epidemiological Studies Depression Scale
EPS Electrophysiologic Studies
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 26684
    JournalTitle: Scandinavian studies in law.
    MedAbbr: Scand Stud Law
    ISSN: 0085-5944
    ESSN:
    IsoAbbr:
    NlmId: 101082931
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Bell-Magendie law
    º§ ¸¶°Õµð ¹ýÄ¢
  • Boyles law
    º¸ÀÏ ¹ýÄ¢
  • Dale-Feldbergs law
    ´ëÀÏ-ÈÔÆ®º£¸£±× ¹ýÄ¢
  • Landouzy-Grasset law
    ¶ûµµ¿ìÁö-±×¶ó¼¼ ¹ýÄ¢
    ´ë³ú ¹Ý±¸ÀÇ Áúȯ¿¡¼­ ¸¶ºñ°¡ ÀÖÀ» °æ¿ì¿¡´Â È¯Ãø ¹æÇâÀ¸·Î, ±×¸®°í °­Á÷ÀÌ ÀÖÀ» °æ¿ì¿¡´Â È¯Ãø ±ÙÀ° ¹æÇâÀ¸·Î ¸Ó¸®°¡ ±â¿î´Ù.
  • Landsteiner's law
    ¶õµå½ºÅ¸ÀÌ³Ê ¹ýÄ¢
    µ¿Á¾ ÀÀÁý¿ø°ú µ¿Á¾ ÀÀÁý¼Ò¿ÍÀÇ ¿ªºñ·Ê.
  • law of diffusion
    È®»ê¹ýÄ¢
    ¸ðµç ¹°ÁúÀº °í³óµµ¿¡¼­ Àú³óµµ·Î ¹°ÁúÀÌ À̵¿ÇÑ´Ù.
  • law of facilitation
    ¼ÒÅëÀÇ ¹ýÄ¢
    ¾î¶² ½Å°æ¿øÀ» Çѹø Ãæµ¿ÀÌ Åë°úÇÏ¸é ´ÙÀ½¿¡µµ ±×°÷À» Åë°úÇϱ⠽±°Ô µÇ¸ç, ±×°ÍÀÌ °ÅµìµÉ ¶§¸¶´Ù Åë°úÇϴµ¥ ÀúÇ×ÀÌ Àû¾îÁø´Ù.
  • law of gravitation
    ÀηÂÀÇ ¹ýÄ¢
    Áß·ÂÀÌ ÀÛ¿ëÇÏ´Â ¹æÇâÀ¸·Î ¸ðµç °ÍÀÌ ÇâÇϰí ÀÖ´Ù.
  • law of inverse square
    Á¦°öÀÇ ¹ýÄ¢
    Á¶»çÀÇ °­µµ´Â Á¶»ç¼±¿ø°ú ÇÇÁ¶»ç ¸é°úÀÇ °Å¸®ÀÇ Á¦°ö¿¡ ¹Ýºñ·ÊÇÑ´Ù.
  • law of prophylaxis for infectious disease
    Àü¿°º´ ¿¹¹æ¹ý
  • law of reciprocity
    »óÈ£ ¹ýÄ¢
  • medical law
    ÀÇ·á¹ý
  • Pascal's law
    ÆÄ½ºÄ®ÀÇ ¹ýÄ¢
    ¾×ü¿¡ ¾î´À ÇÑ Á¡¿¡ °¡ÇØÁø ¾Ð·ÂÀº ¸ðµç ¹æÇâÀ¸·Î µ¿ÀÏÇÏ°Ô ÀüÆÄµÈ´Ù´Â ¹ýÄ¢ÀÌ´Ù.
  • periodic law
    ÁÖ±âÀ²
  • Van't Hoff's law
    ¹ÝÆ® È£ÇÁ½Ä
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
retrospective studies Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
(12 Dec 1998)
pharmalogical studies <pharmacology> Studies to assess the potential harmful or other effects of drugs
(16 Dec 1997)
clinical studies <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product.
(14 Nov 1997)
cohort studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
(12 Dec 1998)
combination studies <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs.
(09 Jan 1998)
multicenter studies Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
(12 Dec 1998)
multivariate studies The use of statistical techniques for the simultaneous investigations of the influence of several variables.
(05 Mar 2000)
preclinical studies <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application.
(14 Nov 1997)
sampling studies Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
(12 Dec 1998)
prospective studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
(12 Dec 1998)
his bundle studies <cardiology> This test studies the electrical activity of the bundle of HIS.
The bundle of HIS is a group of electrical fibres in the heart that are responsible for transmitting the electrical impulses which generate a normal cardiac contraction. This test may be performed in cases of cardiac arrhythmias, to locate a specific area responsible for a conduction defect and to determine the need for cardiac pacemaker placement.
The test involves the passage of a an electrode tipped catheter into the heart. This catheter is usually threaded through a neck, arm or chest vein. Measurements of the HIS bundle can then be performed while standard ECG leads are placed on the arms and legs.
This test carries a small risk of bleeding, arrhythmias, embolism, heart attack and stroke. It is performed by a specially trained cardiologist.
(27 Sep 1997)
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
intracardiac electrophysiology studies <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined.
This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
(27 Sep 1997)
organizational case studies Descriptions and evaluations of specific health care organizations.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scandinavian
    ½ºÄ­µð³ªºñ¾Æ »ç¶÷
  • International Institute for Strategic Studies
    (¿µ)±¹Á¦ Àü·«¿¬±¸¼Ò(I.I.S.S)
  • peace studies
    ÆòÈ­ ¿¬±¸(°­ÁÂ)
  • attorney-at-law
    º¯È£»ç
  • brother-in-law
    ÀÚ¸ÅÀÇ
  • by-law
    Á¶·Ê
  • law
    ¹ý·ü,±ÔÄ¢,¼Ò¼Û
  • law office
    ¹ý·ü »ç¹«¼Ò
  • Coulomb's law
    Äð·ÕÀÇ ¹ýÄ¢ 6
  • Curie law
    (»óÀÚ¼ºÃ¼ÀÇ)Äû¸®ÀÇ ¹ýÄ¢
  • Engel's law
    ¿¨°ÖÀÇ ¹ýÄ¢
  • Gresham's law
    ±×·¹¼ÉÀÇ ¹ýÄ¢(¾ÇÈ­´Â ¾çÈ­¸¦ ±¸ÃàÇÑ´Ù)
  • Grimm's law
    ±×¸²ÀÇ ¹ýÄ¢(Jakob GrimmÀÌ ¹ß°ßÇÑ ÀεµÀ¯·Æ¾îÀÇ ÀÚÀ½ ÀüȯÀÇ ¹ýÄ¡)
  • Roman law
    ·Î¸¶¹ý 
  • blue scy law
    ºÎÁ¤ Áõ±Ç °Å·¡ ´Ü¼Ó¹ý 0
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á